Cargando…
EpCAM-positive circulating tumor cells and serum AFP levels predict outcome after curative resection of hepatocellular carcinoma
Hepatocellular carcinoma (HCC) has high recurrence rates exceeding 50% despite curative resection. The serum biomarker alpha-fetoprotein (AFP) is a well-known prognostic marker for HCC. EpCAM-positive circulating tumor cells (CTC) have a high predictive value for early HCC recurrence after curativel...
Autores principales: | Kocheise, Lorenz, Schoenlein, Martin, Behrends, Berit, Joerg, Vincent, Casar, Christian, Fruendt, Thorben W., Renné, Thomas, Heumann, Asmus, Li, Jun, Huber, Samuel, Lohse, Ansgar W., Pantel, Klaus, Riethdorf, Sabine, Wege, Henning, Schulze, Kornelius, von Felden, Johann |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10682153/ https://www.ncbi.nlm.nih.gov/pubmed/38012205 http://dx.doi.org/10.1038/s41598-023-47580-0 |
Ejemplares similares
-
Hepatocellular carcinoma: Intratumoral EpCAM-positive cancer stem cell heterogeneity identifies high-risk tumor subtype
por: Krause, Jenny, et al.
Publicado: (2020) -
Circulating tumor cells as a preoperative risk marker for occult metastases in patients with resectable cholangiocarcinoma
por: Fründt, Thorben, et al.
Publicado: (2022) -
Biology and clinical relevance of EpCAM
por: Keller, Laura, et al.
Publicado: (2019) -
The detection of EpCAM(+) and EpCAM(–) circulating tumor cells
por: Wit, Sanne de, et al.
Publicado: (2015) -
Expression of EpCAM(MF) and EpCAM(MT) variants in human carcinomas
por: Fong, Dominic, et al.
Publicado: (2014)